CAPN12, on the other hand, exhibits minimal expression in immune cells, with limited evidence linking it to tumor proliferation rather than immune regulation, implying a likely non-immune-specific role (Xia et al., 2023). The gene discussed is CAPN12; the disease is neoplasm.